INS and epilepsy: The most commonly reported medications were piperazine derivatives (R06AE) for allergy, selective beta-2-adrenoreceptor agonists (R03AC) for asthma, methyldopa (C02AB) for cardiovascular diseases, glucocorticoids (H02AB) for rheumatic diseases, fast-acting insulin (A10AB) for diabetes, other antiepileptic drugs (N03AX) for epilepsy, and aminosalicylic acid and similar agents (A07EC) for inflammatory bowel diseases.